Latigo Biotherapeutics, Inc. of THOUSAND OAKS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-13. The offering totals $150.0M, of which $50.0M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Nima Farzan | Director | Thousand Oaks, CA |
| Deborah Palestrant | Director | Berkeley, CA |
| Kevin Raidy | Director | Thousand Oaks, CA |
| Beth Seidenberg | Director | South San Francisco, CA |
| Nancy Stagliano | Director | South San Francisco, CA |
| Jim Tananbaum | Director | Thousand Oaks, CA |
| Tim Walbert | Director | Thousand Oaks, CA |
| Nima Farzan | Executive Officer | Thousand Oaks, CA |
| Tim Lugo | Executive Officer | Thousand Oaks, CA |